By NewsDesk  @infectiousdiseasenews The International AIDS Vaccine Initiative (IAVI) was awarded €22.8 million by the European & Developing Countries Clinical Trials Partnership and the Coalition...

Biotechnology company, INOVIO, announced the first participant was dosed in a Phase 1B clinical trial for INO-4500, its DNA vaccine candidate for Lassa fever, in Ghana. The Phase 1B clinical trial...

Themis Bioscience and CEPI – the Coalition for Epidemic Preparedness Innovations – announced today the first administration to healthy volunteers in a Phase 1 clinical trial with Themis’ vaccine...

By NewsDesk  @bactiman63 Lassa Fever Candidate Vaccine  Inovio Pharmaceuticals, Inc. announced Tuesday announced it has dosed subjects in a Phase 1, first-in-human clinical trial to evaluate INO-4500,...